Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 9/2013

01-11-2013 | Original Paper

Test of a Web-Based Program to Improve Adherence to HIV Medications

Authors: Rebekah K. Hersch, Royer F. Cook, Douglas W. Billings, Seth Kaplan, David Murray, Steven Safren, Justin Goforth, Joy Spencer

Published in: AIDS and Behavior | Issue 9/2013

Login to get access

Abstract

We evaluated the effectiveness of a web-based version of the Life-Steps intervention combined with modules for stress reduction and mood management, designed to improve medication adherence among HIV infected individuals. 168 HIV+ adults were randomized into either the Life-Steps program or a waitlist control condition. All participants completed a baseline assessment and provided a 2-week electronic pill (MEMS) cap baseline reading. Follow up data collection was conducted at 3, 6 and 9 months. Patients in the web-based Life-Steps condition had significantly higher antiretroviral medication adherence rates than patients in the control group over the nine-month period as measured by the MEMS cap. In addition, analysis of viral load data indicated that the program also resulted in a significant decrease in viral load. These findings indicate that a web-based Life-Steps program can be a useful and implementable tool for helping patients living with HIV maintain medication adherence.
Literature
1.
O’Cleirigh C, Safren S. Optimizing the effects of stress management interventions in HIV. Health Psychol. 2008;27:4–14.CrossRef
2.
Safren SA, Otto MW, Worth J, et al. Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behav Res Ther. 2001;39:1151–62.PubMedCrossRef
3.
Safren SA, O’Cleirigh CM, Tan JY, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28:1–10.PubMedCrossRef
4.
Carpenter CJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997: updated recommendations of the international AIDS society-USA panel. JAMA. 1997;277:1962–9.PubMedCrossRef
5.
6.
Goebel FD. Combination therapy from a clinician’s perspective. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:S62–8.PubMedCrossRef
7.
Thompson MA, Aberg JA, Cahn P, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010;304:321–33.PubMedCrossRef
8.
Catz SL, Kelly JA, Bogart LM, et al. Patterns, correlates a barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19:124–33.PubMedCrossRef
9.
Hinkin CH, Barclay TR, Castellon SA, et al. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav. 2007;11(2):185–94.PubMedCrossRef
10.
Safren SA, O’Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80(3):404–15.PubMedCrossRef
11.
Scott-Sheldon LAJ, Carey MP, Vanable PA, Senn TE, Coury-Doniger P, Urban MA. Alcohol consumption, drug use, and condom use among STD clinic patients. J Stud Alcohol Drugs. 2009;70:762–70.PubMed
12.
Safren SA, Otto MW, Worth J. Life-steps: applying cognitive-behavioral therapy to patient adherence to HIV medication treatment. Cogn Behav Pract. 1999;6:332–41.CrossRef
13.
Safren SA, Hendriksen ES, DeSousa N, Boswell SL, Mayer KH. Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care. 2003;15:787–93.PubMedCrossRef
14.
Safren SA, Hendriksen ES, Mayer KH, Pickard R, Otto MW. Cognitive behavioral therapy for HIV medication adherence and depression. Cogn Behav Pract. 2004;11:415–23.CrossRef
15.
Simoni JS, Amico KR, Pearson CR. Malow RM Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Cogn Behav Pract. 2008;10:515–21.
16.
Cook RF, Billings DW, Hersch RK, Back A, Hendrickson A. A field test of a web-based workplace health promotion program to improve dietary practices, reduce stress, and increase physical activity: randomized controlled trial. J Med Internet Res. 2007;9:e17.PubMedCrossRef
17.
Portnoy DB, Scott-Sheldon LAJ, Johnson BT, Carey MP. Computer-delivered interventions for health promotion and behavioral risk reduction: a meta-analysis of 75 randomized controlled trials, 1988–2007. Prev Med. 2008;47:3–16.PubMedCrossRef
18.
Williams GC, Lynch MF, Glasgow RE. Computer-assisted intervention improves patient-centered diabetes care by increasing autonomy support. Health Psychol. 2007;26:728–34.PubMedCrossRef
19.
Noar SM, Black HG, Pierce LB. Efficacy of computer technology-based HIV prevention interventions: a meta-analysis. AIDS. 2009;23:107–15.PubMedCrossRef
20.
Fisher JD, Amico KR, Fisher WA, et al. Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows project. AIDS Behav. 2011;15(8):1635–46.PubMedCrossRef
21.
Billings DW, Cook RF, Hendrickson A, Dove DC. A web-based approach to managing stress and mood disorders in the workforce. J Occup Environ Med. 2008;50:960–8.PubMedCrossRef
22.
Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care. 2000;12:255–66.PubMedCrossRef
23.
Risser J, Jacobson TA, Kripalani S. Development and psychometric evaluation of the self-efficacy for appropriate medication use scale (SEAMS) in low-literacy patients with chronic illness. J Nurs Meas. 2007;15:207–23.CrossRef
24.
Pakenham KI, Rinaldis M. Development of the HIV/AIDS stress scale. Psychol Health. 2002;17:203–19.CrossRef
25.
Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54:1063–70.PubMedCrossRef
26.
Cook RF, Bernstein A, Andrews C. Assessing drug use in the workplace: a comparison of self-report, urinalysis and hair analysis. NIDA research monograph 167. Rockville: National Institute on Drug Abuse; 1997.
27.
Cook RF, Back AS, Trudeau J, McPherson TL. Integrating substance abuse prevention into health promotion programs in the workplace: a social-cognitive intervention targeting the mainstream user. In: Bennett JB, Lehman WEK, editors. Preventing workplace substance abuse: beyond drug testing to wellness. Washington, D.C.: APA Books; 2003. p. 97–134.CrossRef
28.
Cook RF, Hersch RK, Back AS, McPherson TL. The prevention of substance abuse among construction workers: a field test of a social cognitive program. J Prim Prev. 2004;25:337–58.CrossRef
29.
Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. New York: Springer; 2010.CrossRef
30.
Schafer JL. Analysis of incomplete multivariate data. London: Chapman and Hall; 1997.CrossRef
31.
Centers for Disease Control. Estimated HIV incidence among adults and adolescents in the United States, 2007–2010. HIV Surveillance Supplemental Report. 2012;17:4. http://​www.​cdc.​gov/​hiv/​topics/​surveillance/resources/reports/#supplemental.
32.
Government of the District of Columbia, Department of Health. Annual report 2011: HIV/AIDS, hepatitis, STD, and TB epidemiology of the District of Columbia. Washington, DC: Department of Health: HIV/AIDS, Hepatitis, STD, and TB Administration (HAHSTA); 2012.
33.
Centers for Disease Control. Methamphetamine use and HIV risk behaviors among heterosexual men -preliminary results from five northern California counties, December 2002–November 2003. MMWR. 2006;55:273–7.
34.
Molitor F, Truax SR, Ruiz JD, et al. Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J Med. 1998;168:93–7.PubMed
35.
36.
Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357–66.PubMedCrossRef
37.
Shi L, Liu J, Fonseca V, Walker P, Kalsekar A, Pawaskar M. Correlations between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes. 2010;8:99.PubMedCrossRef
38.
Wagner GJ. Predictors of antiretroviral adherence as a measure by self-report, electronic monitoring, and medication diaries. AIDS Patient Care STDS. 2002;16(12):599–608.PubMedCrossRef
39.
Deschamps AE, Van Wijngaerden E, Denhaerynck K, De Geest S, Vandamme AE. Use of electronic monitoring induces a 40-day intervention effect in HIV patients. J Acquir Immune Defic Syndr. 2006;43:247–8.PubMedCrossRef
40.
Zickuhr K, Smith, A. Digital differences. Washington, DC: Pew Research Center’s Internet and American Life Project. 2012. pewinternet.org/Reports/2012/Digital-differences.aspx.
41.
Pop-Eleches C, Thirumurthy H, Habyarimana JP, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25(6):825–34.PubMedCrossRef
Metadata
Title
Test of a Web-Based Program to Improve Adherence to HIV Medications
Authors
Rebekah K. Hersch
Royer F. Cook
Douglas W. Billings
Seth Kaplan
David Murray
Steven Safren
Justin Goforth
Joy Spencer
Publication date
01-11-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue 9/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0535-8

Other articles of this Issue 9/2013

AIDS and Behavior 9/2013 Go to the issue

Original Paper

From Research to Practice: Lay Adherence Counsellors’ Fidelity to an Evidence-Based Intervention for Promoting Adherence to Antiretroviral Treatment in the Western Cape, South Africa

Substantive Review

Microenterprise Development Interventions for Sexual Risk Reduction: A Systematic Review

Original Paper

Supportive-Expressive and Coping Group Teletherapies for HIV-Infected Older Adults: A Randomized Clinical Trial

Original Paper

Use of a Novel Technology to Track Adherence to Product Use in a Microbicide Trial of Short Duration (MTN-007)

Original Paper

WiLLOW: Reaching HIV-Positive African-American Women Through a Computer-Delivered Intervention

Original Paper

A Comparison Study of Methods for Measuring Retention in HIV Medical Care
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits